Lyell Immunopharma, Inc. (LYEL) Dividend Yield, History & Forecast
Lyell Immunopharma, Inc. (LYEL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. market capitalization is approximately $494M.
Frequently Asked Questions about Lyell Immunopharma, Inc. (LYEL)
Is Lyell Immunopharma, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Lyell Immunopharma, Inc. in?▾
Lyell Immunopharma, Inc. (LYEL) operates in the Healthcare sector, specifically the Biotechnology industry.
